What is Transfection Technologies Market Scope?
Transfection is an approach to provide exogenous nucleic acids like DNA, RNA, or oligonucleotide into cells. Such nucleic acids will be transferred by chemical compounds or lipid transfection reagents that promote cellular absorption. This methodology is widely used for genomic studies (cell illustration, testing, RNA interference, in vitro research) however will be conducted for bio-production (vaccine and protein manufacturing) or healthful reasons (animal cell treatment). Nucleic acid delivery to cells will be accomplished by distinct physical techniques, like electroporation, sonoporation, or microinjection; but these procedures are relatively unsafe to cells. Transfection with chemical substances may be a better choice for maintaining healthy cell feasibility.
The Transfection Technologies market study is being classified by Type (Lipofection, Electroporation, Nucleofection and Others), by Application (Research Centers & Academic/Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Transfection Technologies market throughout the predicted period.
Lonza Group (Switzerland), Bio-Rad Laboratories, Inc (United States), Thermo Fisher Scientific (United States), Qiagen NV (Germany), Promega Corporation (United States), SignaGen Laboratories (United States), Merck KGaA (Germany), Altogen Biosystems (United States), Polyplus-transfection SA (United States) and Mirus Bio (United States) are some of the key players profiled in the study.
Segmentation Analysis
Analyst at AMA have segmented the market study of Global Transfection Technologies market by Type, Application and Region.
On the basis of geography, the market of Transfection Technologies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In December 2018, Polyplus-transfection SA declared the release of PEIpro-GMP, a transfection reagent for medical and industrial lentivirus and adeno-associated disease (AAV) tissue & DNA therapy. This reagent was launched to promote the medical stage and the commercialization stage of manufacturing. and In May 2018, Altogen Biosystems released a new version of AltoFect, a second-generation transfection reagent for the hard-to-transfect cell lines to primary cell types. AltoFect transfection reagent appears to have up to 85 percent efficiency of transfection in difficult-to-transfect cells, like B-cells, T-cells, and primary cell cultures. This reagent allows scientists to solve difficulties and constraints linked to primary cells and difficult-to-transfect cell lines.
Influencing Market Trend
- Rising Application of The Transfection Procedures by The Academic Researchers
Market Drivers
- Rising Incidences of Cancer
- Increasing Number of Obese and Overweight Population
Opportunities
- Increase in Research and Development in The Field of Cell-Based Therapies
- Advances in The Cell Research and The Therapeutic Delivery
- Massive Funds by Government and Private Players
Restraints
- High Cost of The Transfection Technologies
Challenges
- Home Brew Reagents Restrict Sale of Commercial Kits
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Transfection Technologies, Venture Capitalists and Private Equity Firms and End-Use Industry
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.